This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Source-linked RPLP1 Western blot protocol options, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-RPLP1 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, source-linked protocol options, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~11.5 kDa | |
| Gel | 15% (standard starting point) | |
| Negative control | Suggested KO / knockdown lysate |
| PTM | Phosphorylated + Acetylated | |
| Caveat | Modification-state controls | |
| Gene-set association | MSigDB C7 membership | |
| Isoform | 2 isoform(s) |
The A07117 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | extracts of various cell lines, (catalog A07117) |
| Gel % | 15% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Short semi-dry transfer; verify retention (standard starting point) |
| Membrane | 0.2 µm PVDF (standard starting point) |
| Blocking | Blocking buffer: 3% nonfat dry milk in TBST (catalog A07117) |
| Primary antibody | A07117 · 1:1000 (catalog A07117) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Goat Anti-Rabbit IgG, 1:10000 (catalog A07117) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL (catalog A07117) |
RPLP1 is predicted at 11.5 kDa; isoforms and modifications could affect migration, but no empirical band size or specific shift is established.
| Band near 11.5 kDa | consistent with the predicted RPLP1 size; confirm identity with antibody controls |
| Two bands near the expected region | could reflect isoforms 1 and 2 if their migration differs |
| Close doublet | could reflect phosphorylation at Ser101; the migration effect is unestablished |
| Higher band | could reflect Ubl conjugation; band identity requires confirmation |
| Predicted RPLP1 mass | places the unmodified sequence near 11.5 kDa |
| Isoform 1 | may migrate differently from isoform 2; its mass is unspecified |
| Isoform 2 | may migrate differently from isoform 1; its mass is unspecified |
| N-acetylalanine at residue 2 | is documented, but a visible size shift is unestablished |
| Phosphoserine at residue 101 | may alter mobility, but a visible shift is unestablished |
| Situation | Likely cause | Next action |
|---|---|---|
| Band higher than expected | possible Ubl conjugation or nonspecific binding | check specificity with RPLP1 knockdown and compare treatment conditions |
| Band lower than expected | possible degradation or nonspecific binding | prepare fresh lysate with protease inhibitors and check RPLP1 knockdown |
| Multiple bands | possible isoforms, phosphorylation states, or nonspecific binding | compare knockdown lanes and test phosphatase treatment |
| Weak or no signal | low RPLP1 recovery or inadequate antibody detection | check loading and transfer with controls and optimize antibody conditions |
| Fragments below expected size | possible proteolysis during sample preparation | use fresh lysate with protease inhibitors and check whether fragments track with RPLP1 knockdown |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No high/medium HPA tissues identified in the supplied evidence. | ||||
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No lower-expression tissue rows available in the supplied evidence. | ||||
Deeper troubleshooting and optimisation questions for RPLP1, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
the supplier A07117 is an anti-RPLP1 antibody listed for human, mouse, and rat. Its Western blot image uses extracts from various cell lines at 1:1000 dilution with 25 µg per lane; the supplied caption does not identify the cell lines or their species.
Which to pick: A07117 is the only listed option and has a Western blot image. Check its listed human, mouse, and rat reactivity against your sample; the image caption does not establish which species were tested.